Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance

References

• Di Angelantonio E, Bhupathiraju SN, Wormser D, Gao P, Kaptoge S, Berrington de Gonzalez A, Cairns BJ, Huxley R. Body-mass index and all-cause mortality: individual- participant-data meta-analysis of 239 prospective studies in four continents. Lancet [Internet]. 2014;388:776–86. doi:10.1016/S0140-6736(16)30175-1.
   Web of Science ®Google Scholar
• Murray CJLL, Lopez AD, Phil D. Measuring the global burden of disease. N Engl J Med. 2013;369:448–57. doi:10.1056/NEJMra1201534. PMID:23902484
   PubMed Web of Science ®Google Scholar
• Reaven GM. Role of insulin resistance in human disease. Diabetes [Internet]. 1988;37:1595–607. doi:10.2337/diab.37.12.1595.
   PubMed Web of Science ®Google Scholar
• Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10–4. doi:10.1136/adc.2003.036467. PMID:15613503
   PubMed Web of Science ®Google Scholar
• Adiels M, Taskinen MR, Borén J. Fatty liver, insulin resistance, and dyslipidemia. Curr Diab Rep. 2008;8:60–4. doi:10.1007/s11892-008-0011-4. PMID:18367000
   PubMed Web of Science ®Google Scholar
• Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer viewpoint of the IARC working group. N Engl J Med. 2016;375:794–8. doi:10.1056/NEJMsr1606602. PMID:27557308
   PubMed Web of Science ®Google Scholar
• Jung KY, Cho SY, Kim HJ, Kim SB, Song IH. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology. J Clin Gastroenterol. 2014;48:883–8. PMID:24440936
   PubMedGoogle Scholar
• Rizzo M, Tyndall EK, Frontoni S, Jacoangeli F, Sarlo F, Panebianco F, Mistorni A, Di Renzo L, Calafiore R, Luca G, et al. Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome. J Endocrinol Invest. 2013;36:527–30. PMID:23612476
   PubMed Web of Science ®Google Scholar
• González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J, Villarreal-Pérez JZ. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf). 2009;71:494–9. doi:10.1111/j.1365-2265.2008.03508.x. PMID:19094069
   PubMed Web of Science ®Google Scholar
• Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Malcolm MM, Roth J. The syndromes of insulin resistance and Acanthosis Nigricans — insulin-receptor disorders in man. N Engl J Med. 1976;294:739–45. doi:10.1056/NEJM197604012941401. PMID:176581
   PubMed Web of Science ®Google Scholar
• Schwartz RA. Acanthosis nigricans. J Am Acad Dermatol. 1994;31:1-19-2. doi:10.1016/S0190-9622(94)70128-8. PMID:8021347
   PubMed Web of Science ®Google Scholar
• Hermanns-Lê T, Scheen A, Piérard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol. 2004;5:199–203. doi:10.2165/00128071-200405030-00008. PMID:15186199
   PubMed Web of Science ®Google Scholar
• Aswani R, Lochow A, Dementieva Y, Lund VA, Elitsur Y. Acanthosis nigricans as a clinical marker to detect insulin resistance in Caucasian children from West Virginia. Cllin Pediatr (Phila). 2011;50:1057–61. doi:10.1177/0009922811414288.
   PubMed Web of Science ®Google Scholar
• Brockow K, Steinkraus V, Rinninger F, Abeck D, Ring J. Acanthosis nigricans: a marker for hyperinsulinemia. Pediatr Dermatol. 1995;12:323–6. doi:10.1111/j.1525-1470.1995.tb00193.x. PMID:8747578
   PubMed Web of Science ®Google Scholar
• Hermanns-Le T, Hermanns JF, Pierard GE. Juvenile Acanthosis Nigricans and Insulin Resistance. Pediatr Dermatol. 2002;19:12–4. doi:10.1046/j.1525-1470.2002.00013.x. PMID:11860562
   PubMed Web of Science ®Google Scholar
• Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med. 1989;87:269–72. doi:10.1016/S0002-9343(89)80149-4. PMID:2773965
   PubMed Web of Science ®Google Scholar
• Gómez-Flores M, González-Saldivar G, Santos-Santos O, Álvarez-Villalobos N, Rodríguez-Gutiérrez R, Tellez-Hinojosa C, González-González J. Implications of a clinically ignored site of acanthosis nigricans: the knuckles. Exp Clin Endocrinol Diabetes. 2015;123:27–33. PMID:25314648
   PubMed Web of Science ®Google Scholar
• Hirschler V, Aranda C, Adriana O, Gonzalez C, Jadzinsku M. Is acanthois nigricans a marker of insulin resistance in obese children? Diabetes Care. 2002;25:2353. doi:10.2337/diacare.25.12.2353. PMID:12453987
   PubMed Web of Science ®Google Scholar
• Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Grüters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity – a problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004;151:199–206. doi:10.1530/eje.0.1510199. PMID:15296475
   PubMed Web of Science ®Google Scholar
• Sadeghian G, Ziaie H, Amini M, Ali Nilfroushzadeh M. Evaluation of insulin resistance in obese women with and without acanthosis nigricans. J Dermatol. 2009;36:209–12. doi:10.1111/j.1346-8138.2009.00625.x. PMID:19348659
   PubMed Web of Science ®Google Scholar
• Nascimiento Kluczynik C, Ferreira Souza L, de Lira Albuquerque F, Soares Mariz L, Beserra Solano G, Muniz Medeiros C. Acanthosis nigricans and insulin resistance in overweight children and adolescents. An Bras Dermatol. 2012;87:531–7. doi:10.1590/S0365-05962012000400002. PMID:22892764
   PubMed Web of Science ®Google Scholar
• Stuart CA, Smith MM, Gilkison CR, Shaheb S, Stahn RM. Acanthosis nigricans among native Americans: An indicator of high diabetes risk. Am J Public Heal. 1994;84:1839–42. doi:10.2105/AJPH.84.11.1839.
   PubMed Web of Science ®Google Scholar
• Bellot-Rojas P, Posadas-Sanchez R, Caracas-Portilla N, Zamora-González J, Cardoso-Saldaña G, Jurado-Santacruz F, Posadas-Romero C. Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans. J Drugs Dermatol. 2006;5:884–9. PMID:17039655
   PubMedGoogle Scholar
• Burke J, Hale D, Hazuda H, Stern M. A Quantitative Scale of Acanthosis Nigricans. Diabetes Care. 1999;22:1655–9. doi:10.2337/diacare.22.10.1655. PMID:10526730
   PubMed Web of Science ®Google Scholar
• Santoro N, Amato A, Grandone A, Brienza C, Savarese P, Tartaglione N, Marzuillo P, Perrone L, Miraglia Del Giudice E. Predicting metabolic syndrome in obese children and adolescents: Look, measure and ask. Obes Facts. 2013;6:48–56. doi:10.1159/000348625. PMID:23429241
   PubMed Web of Science ®Google Scholar
• Lopez-Alvarenga JC, García-Hidalgo L, Landa-Anell MV, Santos-Gómez R, González-Barranco J, Comuzzie A. Influence of skin color on the diagnostic utility of clinical acanthosis nigricans to predict insulin resistance in obese patients. Arch Med Res. 2006;37:744–8. doi:10.1016/j.arcmed.2005.12.007. PMID:16824934
   PubMed Web of Science ®Google Scholar
• Mustafa M, Moghrabi N, Bin-Abbas B. Hypochondroplasia, acanthosis nigricans, and insulin resistance in a child with FGFR3 mutation: Is it just an association? Case Rep Endocrinol. 2014;2014:840492. PMID:25505998
   PubMedGoogle Scholar
• Menon VU, Kumar KV, Gilchrist A, Sundaram KR, Jayakumar RV, Nair V, Kumar H. Acanthosis Nigricans and insulin levels in a south Indian population-(ADEPS paper 2). Obes Res Clin Pr. 2008;2:43–50. doi:10.1016/j.orcp.2007.12.001.
   Web of Science ®Google Scholar
• Pinheiro A, Rojas P, Carrasco F, Gomez P, Mayas N, Morales I. Acanthosis nigricans as an indicator of insulin resistance in Chilean adult population. Nutr Hosp [Internet]. 2011;26:940–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22072335
   PubMed Web of Science ®Google Scholar
• Stuart CA, Gilkison CR, Keenan BS, Nagamani M. Hyperinsulinemia and acanthosis nigricans in African Americans. J Natl Med Assoc. 1997;89:523–7. PMID:9264219
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Camastra S, Gastaldelli A, Maria Sironi A, Natali A, Muscelli E, Mingrone G, Mari A. Beta-cell function in obesity: Effects of weight loss. Diabetes. 2004;53(Suppl 3):S26–33. doi:10.2337/diabetes.53.suppl_3.S26. PMID:15561918
   PubMedGoogle Scholar
• Vella CA, Burgos X, Ellis CJ, Zubia RY, Ontiveros D, Reyes H, Lozano C. Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight Hispanic women. Diabetes Care. 2013;36:1377–83. doi:10.2337/dc12-1550. PMID:23275356
   PubMed Web of Science ®Google Scholar
• Borai A, Livingstone C, Kaddam I, Ferns G. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011;11:158. doi:10.1186/1471-2288-11-158. PMID:22112229
   PubMed Web of Science ®Google Scholar
• Cersosimo E, Solis-Herrera C, Trautmann M, Malloy J, Triplitt C. Assessment of pancreatic β-cell function: Review of methods and clinical applications. Curr Diabetes Rev. 2014;10:2–42. doi:10.2174/1573399810666140214093600. PMID:24524730
   PubMedGoogle Scholar
• DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–23. PMID:382871
   PubMed Web of Science ®Google Scholar
• Szosland K, Lewiński A. In quest for method of insulin resistance assessment in everyday clinical practice-Insulin resistance indices. Diabetes Metab Syndr Clin Res Rev. 2015;1:120–5.
   Google Scholar
• Garnett SP, Srinivasan S, Birt SG, Ambler GR, Lawrie EA, Cowell CT, Craig ME. Evaluation of glycaemic status in young people with clinical insulin resistance; Fasting glucose, fasting insulin or an oral glucose tolerance test? Clin Endocrinol. 2010;72:475–80. doi:10.1111/j.1365-2265.2009.03677.x.
   PubMed Web of Science ®Google Scholar
• Murguía-Romero M, Jiménez-Flores J, Mendes-Criz A, Sigrist-Flores S, Villalobos-Molina R. Insulin and HOMA-IR in healthy young Mexicans: A cut-off points proposal. Intern Med Open Access. 2014;1:1–5.
   Google Scholar
• Aguilar-Salinas CA, Olaiz G, Valles V, Torres JM, Gómez Pérez FJ, Rull JA, Rojas R, Franco A, Sepulveda J. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J Lipid Res. 2001;42:1298–307. PMID:11483632
   PubMed Web of Science ®Google Scholar
• Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasaka S, Tokuyama K, Nakai Y. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism. 2000;49:1001–5. doi:10.1053/meta.2000.7735. PMID:10954017
   PubMed Web of Science ®Google Scholar
• Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: Developments in research and prospects for the future. Drug Discov Ther. 2015;9:380–5. doi:10.5582/ddt.2015.01207. PMID:26781921
   PubMed Web of Science ®Google Scholar
• Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254–66. doi:10.1056/NEJMra1514009. PMID:28099824
   PubMed Web of Science ®Google Scholar
• Defronzo RA. From the triumvirate to the ominous octet: A new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773–95. doi:10.2337/db09-9028. PMID:19336687
   PubMed Web of Science ®Google Scholar
• Caceres M, Teran CG, Rodriguez S, Medina M. Prevalence of insulin resistance and its association with metabolic syndrome criteria among Bolivian children and adolescents with obesity. BMC Pediatr. 2008;8:31. doi:10.1186/1471-2431-8-31. PMID:18700035
   PubMed Web of Science ®Google Scholar
• Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. doi:10.1007/BF00280883. PMID:3899825
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [Internet]. 2006; Available from: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf
   Google Scholar
• Fitzpatrick T. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–71. doi:10.1001/archderm.1988.01670060015008. PMID:3377516
   PubMed Web of Science ®Google Scholar